The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 ...

Pakistan hope to ride the wave of momentum from the ODI series win while an understrength home side are looking to build to ...

When the Brooklyn Nets faced the Boston Celtics in recent seasons, the results did not favor Brooklyn.The Nets nearly left ...

Profit after tax came in ₹38.4 crore in Q2 of FY25, a recovery from a net loss of ₹11.8 crore in the first quarter of this ...

Research and Development (R&D) Expenses: R&D expenses were $16.0 million for the three months ended September 30, 2024, as compared to $14.0 million for the same period in 2023. The increase was ...

Sammy Smith is one of the nation’s emerging two-sport athletes with a rare combination. She is an elite soccer player — a ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement to acquire Increlex® (mecasermin injection)Q3 2024 produ ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

While gold understandably grabs the headlines, rare coins made of silver and other metals can also deliver huge returns.

Ohio State fans who are ticked off about the Buckeyes playing their huge game against Indiana next week at noon on Saturday ...

Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer's; on track to generate top-line data H1 2025 - - Recent third-party clinical data esta ...

"The third quarter was one of the most exciting and transformational periods in Zevra's journey ... With the approval of MIPLYFFA, Zevra received a rare pediatric disease Priority Review Voucher (PRV) ...